医学
周细胞
转移
靶向治疗
放射治疗
血管内皮生长因子
癌症研究
血管生成
免疫系统
受体
癌细胞
免疫学
癌症
病理
内科学
内皮干细胞
血管内皮生长因子受体
生物
体外
生物化学
作者
Mao-Bin Meng,Nicholas G. Zaorsky,Lei Deng,Nicholas G. Zaorsky,Chao Jiang,Lu Zhao,Zhiyong Yuan,Ping Wang
出处
期刊:Future Oncology
[Future Medicine]
日期:2014-08-21
卷期号:11 (1): 169-179
被引量:63
摘要
Pericytes, which envelope the vascular endothelium throughout the body, are often targeted to promote vascular normalization and restore normal function of blood vessels in cancer treatment. The goals of pericyte-targeted therapy tend to promote proper vascular normalization of the tumor. Tumor vascular normalization prevents metastasis, increases tumor oxygenation (making radiation more effective in killing tumor cells), optimizes Starling forces to increase delivery of cancer cell-directed therapies (e.g., chemotherapy or targeted agents), increases the efficacy of focal therapies (e.g., surgery or radiation), and increases recognition by the host immune system. We review how approaches in pericyte-targeted therapy aim to reach a balance between pro-angiogenic and anti-angiogenic function (i.e., by targeting platelet-derived growth factor beta receptors, vascular endothelial growth factor receptors and Tie-2) for tumor vascular normalization.
科研通智能强力驱动
Strongly Powered by AbleSci AI